Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of clinical manifestations and a relapsing-remitting course. New data regarding pathogenic pathways, biomarkers and clinical manifestations of SLE are emerging, and new drugs and therapeutic protocols have been proposed to improve the control of disease activity. Furthermore, new insights into comorbidities and reproductive health in SLE patients are constantly emerging. This annual review aims to summarise the most relevant data on SLE that was published in 2022.
Zucchi, D., Silvagni, E., Elefante, E., Signorini, V., Cardelli, C., Trentin, F., et al. (2023). Systemic lupus erythematosus: one year in review 2023. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 41(5), 997-1008 [10.55563/clinexprheumatol/4uc7e8].
Systemic lupus erythematosus: one year in review 2023
Cardelli C.;
2023-01-01
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of clinical manifestations and a relapsing-remitting course. New data regarding pathogenic pathways, biomarkers and clinical manifestations of SLE are emerging, and new drugs and therapeutic protocols have been proposed to improve the control of disease activity. Furthermore, new insights into comorbidities and reproductive health in SLE patients are constantly emerging. This annual review aims to summarise the most relevant data on SLE that was published in 2022.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1314994
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo